Active13399379Private limited companyWalton-On-Thames

GLYCOS BIOMEDICAL LTD

Significant control: Pervinder Singh Bhogal (25–50%), Ounali Sherali Jaffer (25–50%) and 1 more

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Glycos Biomedical Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Glycos Biomedical Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

GLYCOS BIOMEDICAL LTD is an active private limited company (company number 13399379) incorporated on 14 May 2021, registered in Walton-On-Thames. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.

There are 151 companies in research and experimental development on biotechnology in Greater London with filed accounts; the median reports net assets of £200 and is 8 years old.

Ownership and control

3 active

PS
Dr Pervinder Singh Bhogal
Individual · since 14 May 2021
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
OS
Dr Ounali Sherali Jaffer
Individual · since 14 May 2021
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
MZ
Muhammad Zubair Ahmad
Individual · since 11 April 2023
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 14 May 20215 yrs ago
First accounts due: 14 February 20231353 days overdue
Confirmation statement due: 28 May 2027in 211 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Total Exemption Full

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 14 May 2021
Accounts past their due dateDue 14 February 2023

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

28 May 2027Confirmation statement duein 211 days
14 Feb 2023First accounts due1353 days overdue
14 May 2021Incorporated

Similar companies in Greater London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 14 May 2021 · in May 2021.

Reminders for GLYCOS BIOMEDICAL LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.